View Financial HealthWacker Chemie 배당 및 자사주 매입배당 기준 점검 0/6Wacker Chemie 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률1.8%배당 성장률14.6%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트공시 • Mar 13Wacker Chemie AG announces Annual dividend, payable on May 06, 2025Wacker Chemie AG announced Annual dividend of EUR 2.5000 per share payable on May 06, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.Declared Dividend • Mar 14Dividend of €3.00 announcedShareholders will receive a dividend of €3.00. Ex-date: 9th May 2024 Payment date: 13th May 2024 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Upcoming Dividend • May 12Upcoming dividend of €12.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 23 May 2023. Payout ratio is a comfortable 48% and the cash payout ratio is 85%. Trailing yield: 8.6%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.6%).Upcoming Dividend • May 16Upcoming dividend of €8.00 per shareEligible shareholders must have bought the stock before 23 May 2022. Payment date: 25 May 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.3%). In line with average of industry peers (5.1%).Upcoming Dividend • May 06Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 17 May 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).모든 업데이트 보기Recent updates공시 • Mar 23Wacker Chemie AG, Annual General Meeting, May 06, 2026Wacker Chemie AG, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.공시 • Dec 02+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2025 Results on Mar 11, 2026Wacker Chemie AG announced that they will report fiscal year 2025 results on Mar 11, 2026공시 • Sep 22Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)공시 • Mar 25Wacker Chemie AG, Annual General Meeting, May 07, 2025Wacker Chemie AG, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.공시 • Mar 13Wacker Chemie AG announces Annual dividend, payable on May 06, 2025Wacker Chemie AG announced Annual dividend of EUR 2.5000 per share payable on May 06, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.Reported Earnings • Oct 29Third quarter 2024 earnings: Revenues in line with analyst expectationsThird quarter 2024 results: Revenue: €1.49b (down 2.2% from 3Q 2023). Net income: €44.2m (up 58% from 3Q 2023). Profit margin: 3.0% (up from 1.8% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.공시 • Oct 23+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €93.62, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 29% over the past three years.Reported Earnings • Jul 28Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: €0.58 (down from €2.38 in 2Q 2023). Revenue: €1.47b (down 16% from 2Q 2023). Net income: €29.0m (down 75% from 2Q 2023). Profit margin: 2.0% (down from 6.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 3.5%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Reported Earnings • Apr 26First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2024 results: EPS: €0.89 (down from €2.90 in 1Q 2023). Revenue: €1.49b (down 15% from 1Q 2023). Net income: €44.2m (down 69% from 1Q 2023). Profit margin: 3.0% (down from 8.3% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 71%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.Declared Dividend • Mar 14Dividend of €3.00 announcedShareholders will receive a dividend of €3.00. Ex-date: 9th May 2024 Payment date: 13th May 2024 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Price Target Changed • Jan 17Price target decreased by 9.1% to €124Down from €137, the current price target is an average from 14 analysts. New target price is 28% above last closing price of €96.88. Stock is down 31% over the past year. The company is forecast to post earnings per share of €6.01 for next year compared to €25.18 last year.공시 • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024Reported Earnings • Oct 27Third quarter 2023 earnings: EPS misses analyst expectationsThird quarter 2023 results: EPS: €0.56 (down from €5.08 in 3Q 2022). Revenue: €1.52b (down 29% from 3Q 2022). Net income: €33.5m (down 87% from 3Q 2022). Profit margin: 2.2% (down from 12% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 7.4%. Revenue is forecast to stay flat during the next 3 years compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 7.6% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).Reported Earnings • Jul 30Second quarter 2023 earnings: EPS exceeds analyst expectationsSecond quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 2.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.공시 • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 22% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (129% cash payout ratio). Share price has been volatile over the past 3 months (6.5% average weekly change).공시 • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.Upcoming Dividend • May 12Upcoming dividend of €12.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 23 May 2023. Payout ratio is a comfortable 48% and the cash payout ratio is 85%. Trailing yield: 8.6%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.6%).공시 • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €25.18 (up from €16.24 in FY 2021). Revenue: €8.21b (up 32% from FY 2021). Net income: €1.25b (up 55% from FY 2021). Profit margin: 15% (up from 13% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.4%. Revenue is expected to decline by 2.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to €132, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 119% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €127 per share.Buying Opportunity • Nov 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be €149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 102%. Revenue is forecast to decline by 11% in 2 years. Earnings is forecast to decline by 56% in the next 2 years.공시 • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023Reported Earnings • Aug 03Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 1.1%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 16Upcoming dividend of €8.00 per shareEligible shareholders must have bought the stock before 23 May 2022. Payment date: 25 May 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.3%). In line with average of industry peers (5.1%).Reported Earnings • May 02First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 7.8%, compared to a 8.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 18Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 5.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 23% per year.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to €130, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 43% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €119 per share.Valuation Update With 7 Day Price Move • Jan 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €125, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €214 per share.Buying Opportunity • Jan 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be €189, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. The company has become profitable over the last year.Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS €4.90 (vs €1.30 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €1.66b (up 40% from 3Q 2020). Net income: €248.7m (up 267% from 3Q 2020). Profit margin: 15% (up from 5.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.Executive Departure • May 14CEO, President & Member of Executive Board Rudolf Staudigl has left the companyOn the 12th of May, Rudolf Staudigl's tenure as CEO, President & Member of Executive Board of the company ended after 13.0 years in the role. We don't have any record of a personal shareholding under Rudolf's name. A total of 3 executives have left over the last 12 months. Under Rudolf's leadership, the company delivered a total shareholder return of -0.9%.Upcoming Dividend • May 06Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 17 May 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).Reported Earnings • May 03First quarter 2021 earnings released: EPS €2.06 (vs €1.31 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €1.36b (up 14% from 1Q 2020). Net income: €106.6m (up 55% from 1Q 2020). Profit margin: 7.8% (up from 5.8% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 18Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €4.69b (down 4.8% from FY 2019). Net income: €189.2m (up €831.8m from FY 2019). Profit margin: 4.0% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Feb 03New 90-day high: €128The company is up 50% from its price of €85.26 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €56.09 per share.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 WCH 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: WCH 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Wacker Chemie 배당 수익률 vs 시장WCH의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (WCH)0%시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Chemicals)3.7%분석가 예측 (WCH) (최대 3년)1.8%주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 WCH 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 WCH 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: WCH German 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: WCH 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 13:55종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Wacker Chemie AG는 31명의 분석가가 다루고 있습니다. 이 중 13명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Gerhard SchwarzBaader Helvea Equity ResearchKonstantin WiechertBaader Helvea Equity ResearchLaura Lopez PinedaBaader Helvea Equity Research28명의 분석가 더 보기
공시 • Mar 13Wacker Chemie AG announces Annual dividend, payable on May 06, 2025Wacker Chemie AG announced Annual dividend of EUR 2.5000 per share payable on May 06, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.
Declared Dividend • Mar 14Dividend of €3.00 announcedShareholders will receive a dividend of €3.00. Ex-date: 9th May 2024 Payment date: 13th May 2024 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Upcoming Dividend • May 12Upcoming dividend of €12.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 23 May 2023. Payout ratio is a comfortable 48% and the cash payout ratio is 85%. Trailing yield: 8.6%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.6%).
Upcoming Dividend • May 16Upcoming dividend of €8.00 per shareEligible shareholders must have bought the stock before 23 May 2022. Payment date: 25 May 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.3%). In line with average of industry peers (5.1%).
Upcoming Dividend • May 06Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 17 May 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).
공시 • Mar 23Wacker Chemie AG, Annual General Meeting, May 06, 2026Wacker Chemie AG, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.
공시 • Dec 02+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2025 Results on Mar 11, 2026Wacker Chemie AG announced that they will report fiscal year 2025 results on Mar 11, 2026
공시 • Sep 22Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)Wacker Chemie AG(XTRA:WCH) dropped from FTSE All-World Index (USD)
공시 • Mar 25Wacker Chemie AG, Annual General Meeting, May 07, 2025Wacker Chemie AG, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.
공시 • Mar 13Wacker Chemie AG announces Annual dividend, payable on May 06, 2025Wacker Chemie AG announced Annual dividend of EUR 2.5000 per share payable on May 06, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.
Reported Earnings • Oct 29Third quarter 2024 earnings: Revenues in line with analyst expectationsThird quarter 2024 results: Revenue: €1.49b (down 2.2% from 3Q 2023). Net income: €44.2m (up 58% from 3Q 2023). Profit margin: 3.0% (up from 1.8% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Germany.
공시 • Oct 23+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025
Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €93.62, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 29% over the past three years.
Reported Earnings • Jul 28Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: €0.58 (down from €2.38 in 2Q 2023). Revenue: €1.47b (down 16% from 2Q 2023). Net income: €29.0m (down 75% from 2Q 2023). Profit margin: 2.0% (down from 6.7% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 3.5%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Reported Earnings • Apr 26First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2024 results: EPS: €0.89 (down from €2.90 in 1Q 2023). Revenue: €1.49b (down 15% from 1Q 2023). Net income: €44.2m (down 69% from 1Q 2023). Profit margin: 3.0% (down from 8.3% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 71%. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.
Declared Dividend • Mar 14Dividend of €3.00 announcedShareholders will receive a dividend of €3.00. Ex-date: 9th May 2024 Payment date: 13th May 2024 Dividend yield will be 2.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 56% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Price Target Changed • Jan 17Price target decreased by 9.1% to €124Down from €137, the current price target is an average from 14 analysts. New target price is 28% above last closing price of €96.88. Stock is down 31% over the past year. The company is forecast to post earnings per share of €6.01 for next year compared to €25.18 last year.
공시 • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024
Reported Earnings • Oct 27Third quarter 2023 earnings: EPS misses analyst expectationsThird quarter 2023 results: EPS: €0.56 (down from €5.08 in 3Q 2022). Revenue: €1.52b (down 29% from 3Q 2022). Net income: €33.5m (down 87% from 3Q 2022). Profit margin: 2.2% (down from 12% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 7.4%. Revenue is forecast to stay flat during the next 3 years compared to a 1.9% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 7.6% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).
Reported Earnings • Jul 30Second quarter 2023 earnings: EPS exceeds analyst expectationsSecond quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 2.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.
공시 • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).
New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 22% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (129% cash payout ratio). Share price has been volatile over the past 3 months (6.5% average weekly change).
공시 • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.
Upcoming Dividend • May 12Upcoming dividend of €12.00 per share at 8.6% yieldEligible shareholders must have bought the stock before 19 May 2023. Payment date: 23 May 2023. Payout ratio is a comfortable 48% and the cash payout ratio is 85%. Trailing yield: 8.6%. Within top quartile of German dividend payers (4.6%). Higher than average of industry peers (5.6%).
공시 • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.
Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €25.18 (up from €16.24 in FY 2021). Revenue: €8.21b (up 32% from FY 2021). Net income: €1.25b (up 55% from FY 2021). Profit margin: 15% (up from 13% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.4%. Revenue is expected to decline by 2.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 64% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to €132, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 119% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €127 per share.
Buying Opportunity • Nov 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be €149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 102%. Revenue is forecast to decline by 11% in 2 years. Earnings is forecast to decline by 56% in the next 2 years.
공시 • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023
Reported Earnings • Aug 03Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) also surpassed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 1.1%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 16Upcoming dividend of €8.00 per shareEligible shareholders must have bought the stock before 23 May 2022. Payment date: 25 May 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.3%). In line with average of industry peers (5.1%).
Reported Earnings • May 02First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.0%. Earnings per share (EPS) also surpassed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 7.8%, compared to a 8.9% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 18Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 5.3% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 23% per year.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to €130, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 43% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €119 per share.
Valuation Update With 7 Day Price Move • Jan 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €125, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €214 per share.
Buying Opportunity • Jan 18Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be €189, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. The company has become profitable over the last year.
Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS €4.90 (vs €1.30 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €1.66b (up 40% from 3Q 2020). Net income: €248.7m (up 267% from 3Q 2020). Profit margin: 15% (up from 5.7% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.
Executive Departure • May 14CEO, President & Member of Executive Board Rudolf Staudigl has left the companyOn the 12th of May, Rudolf Staudigl's tenure as CEO, President & Member of Executive Board of the company ended after 13.0 years in the role. We don't have any record of a personal shareholding under Rudolf's name. A total of 3 executives have left over the last 12 months. Under Rudolf's leadership, the company delivered a total shareholder return of -0.9%.
Upcoming Dividend • May 06Upcoming dividend of €2.00 per shareEligible shareholders must have bought the stock before 13 May 2021. Payment date: 17 May 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (3.5%).
Reported Earnings • May 03First quarter 2021 earnings released: EPS €2.06 (vs €1.31 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €1.36b (up 14% from 1Q 2020). Net income: €106.6m (up 55% from 1Q 2020). Profit margin: 7.8% (up from 5.8% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 18Full year 2020 earnings releasedThe company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €4.69b (down 4.8% from FY 2019). Net income: €189.2m (up €831.8m from FY 2019). Profit margin: 4.0% (up from net loss in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Feb 03New 90-day high: €128The company is up 50% from its price of €85.26 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €56.09 per share.